The global chronic wounds treatment market size is estimated to be valued at USD 16.63 Billion in 2025. It is forecasted to reach a valuation of USD 27.23 Billion by 2032, by exhibiting a CAGR of 7.3% throughout the forecast period (2025-2032).
The high prevalence of diabetes among the elderly populace is one of the biggest drivers of the chronic wounds treatment market. It is facilitated by government initiatives aimed at raising awareness about chronic wounds.
But the high costs of treatment and lack of reimbursement policies can impede the market growth.
Key Market Insights
The chronic wounds treatment market is anticipated to be influenced by the integration of regenerative and cellular therapies, as well as AI-enabled wound management systems.
The full report is now available for purchase: https://www.coherentmi.com/industry-reports/chronic-wounds-treatment-market
Chronic Wounds Treatment Market Report Coverage
|
Report Coverage |
Details |
|
Market Revenue in 2025 |
USD 16.63 Billion |
|
Estimated Value by 2032 |
USD 27.23 Billion |
|
Growth Rate |
7.3% |
|
Historical Data |
2020–2024 |
|
Forecast Period |
2025–2032 |
|
Forecast Units |
Value (USD billion) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
|
|
Geographies Covered |
North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Italy, Spain, U.K., Germany, France, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa) |
|
Growth Drivers |
|
|
Opportunities |
|
|
Trends |
|
|
Restraints & Challenges |
|
Market Dynamics
The high numbers of cases of biofilm formation and infections, which cause delayed wound healing, are expected to provide opportunities for treatments in the chronic wounds treatment market. The time taken by traditional diagnostics to determine the root cause has paved the way for CT scanning and autofluorescence imaging.
The development of comprehensive chronic wound management solutions has culminated in the innovation of smart bandages. iCares , a microfluidic wearable bandage, developed in a joint collaboration between researchers from the Keck School of Medicine of USC and California Institute of Technology can provide real-time status updates on chronic wounds. The study published on April 23, 2025, showcased the potential of molecular biomarkers in chronic wound treatment.
Additionally, the development of a combined drug therapy for combating the bacterium Pseudomonas aeruginosa has brought relief to patients with chronic wounds. A team of researchers at the University of Oregon, U.S., discovered that the mixture of small doses of chlorate with existing antibiotics can eliminate the growth cycle of the bacterium. The study published on September 29, 2025, highlighted the use of chlorate to disrupt the nitrate respiration pathway. This can pave the way for new avenues in the chronic wounds treatment market and the development of new therapies for combating persistent bacterial infections.
Market Opportunity: New Wound Healing Solutions
Diabetic foot ulcers (DFU) can cause inflammation, infection, and increased pain. This has led to diabetes-led foot amputation numbers to increase year-on-year. A team of researchers from leading Chinese institutions discovered a new treatment for faster healing of DFU.
An innovative wound dressing containing miR-221OE-sEVs, i.e., engineered extracellular vesicles that enhance wound healing and encourage faster repair, was discovered by an experiment on rats on June 13, 2025. The use of technology for treating vascular diseases, such as cartilage regeneration, can widen the scope of the chronic wounds treatment market.
Market Challenge: Lack of Skilled Professionals
The lack of skilled professionals in advanced wound care can hamper the market growth. This is purported by the large numbers of persons with diabetes, coupled with the increasing number of cases of cancers that cause chronic wounds, highlight the need for skilled professionals. The lack of training in advanced wound care, combined with inadequate education among existing healthcare personnel, can increase the burden on healthcare systems.
However, the publication of a manual in India on negative pressure wound therapy (NPWT), for chronic wound management, on July 08, 2025, can educate medical professionals. The use of the manual in assisting hospitals in transitioning to a proactive model, rather than a reactive one, can bode favorably for the market.
Analyst’s View
Recent Developments
The BioREtain method developed by BioStem Technologies, Inc., was used in the wound coverings, VENDAJE, a part of the allograft portfolio, on April 01, 2025. It is used in the treatment of patients with chronic wounds.
Competitor Insights
Market Segmentation
Regional Insights
Related Reports :